Brunei to end early endemic phase, more Covid-19 restrictions to be eased

According to Brunei's Covid-19 Steering Committee, some existing Covid-19 guidelines will be updated beginning June 1. PHOTO: PIXABAY

BANDAR SERI BEGAWAN (XINHUA) - Brunei will end its Early Endemic Phase on May 31, and the guidelines for Covid-19 control measures will be updated from June.

As part of Brunei's National Covid-19 Recovery Framework, the country moved to the Early Endemic Phase in December last year, when local infections gradually dropped after the country imposed the strictest social distancing measures, including working from home and a curfew.

According to Brunei's Covid-19 Steering Committee, some existing Covid-19 guidelines will be updated beginning June 1, when there will be no limitation on the capacity of mass gatherings at home.

All sporting activities including competitions or matches are allowed without limitation on the number of spectators. Food preparation for any event including buffet meals at any premises is allowed.

There will be no age restriction for all congregations at mosques to perform religious activities, and face masks should be worn in public buildings, as well as in crowded places outdoors.

These moves were made considering the stable Covid-19 situation, high vaccination rates, and low bed occupancy rates at isolation centres in the country, the committee said on Tuesday (May 24).

"To this end, we are able to return to our daily lives by adapting to the new normal," the committee added, saying that the government is monitoring and reviewing requirements for reducing other restrictions including code scans and the opening of borders.

"The outcome of these evaluations, subject to the current situation, will be announced to the public at a later date," the committee said.

Brunei reported 246 new Covid-19 cases on Tuesday, bringing the national tally to 147,021. As of Monday, 69.7 per cent of Brunei's population have received three doses of vaccines.

The Covid-19 vaccines from Pfizer-BioNTech, Moderna, AstraZeneca, and China's Sinopharm are administered in Brunei. Currently, 1,633 active cases are being treated and monitored in Brunei, with 145,166 recoveries.

Join ST's Telegram channel and get the latest breaking news delivered to you.